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What are the combined effects of negative emotions and illness cognitions on self-care in 
people with Type 2 diabetes? A longitudinal structural equation model 
Abstract 
Objective To explore whether negative emotions mediate the effect of diabetes cognitions on 
diabetes self-care and conversely whether diabetes cognitions mediate the effect of negative 
emotions on diabetes self-care. 
Design Longitudinal observational study in adults with Type 2 diabetes. 
Main outcome measures Self-reported depression and anxiety (Diabetes Wellbeing 
Questionnaire), cognitions (Illness Perceptions Questionnaire-Revised; Beliefs about 
Medicines Questionnaire), and diabetes self-care (Summary of Diabetes Self-Care Activities 
Scale) were completed at baseline and six months. Analyses used structural equation 
modelling.  
Results Baseline medication concerns were associated with elevated symptoms of depression 
and anxiety at follow-up, but emotions did not mediate medication concern’s effect on 
diabetes self-care.  Baseline depression and anxiety symptoms were associated with specific 
diabetes cognitions over time, but these cognition domains did not mediate emotion’s effect 
on diabetes self-care. Personal control remained independent of emotions and was associated 
with diabetes self-care over time. 
Conclusions Negative emotions did not act directly or alongside cognitions to influence 
diabetes self-care. The reciprocal relationship between diabetes cognitions and emotions 
suggests cognitive restructuring, in addition to other mood management intervention 
techniques would likely improve the emotional wellbeing of adults with Type 2 diabetes.  
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Likewise, personal control beliefs are likely important intervention targets for improving self-
care.    
Key words: 
     Depression, anxiety, illness cognitions, diabetes self-care, structural equation modelling, 
longitudinal
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Introduction 1 
 2 
In adults with diabetes, symptoms of depression and anxiety are prevalent (Anderson, 3 
Freedland, Clouse, & Lustman, 2001; Grigsby, Anderson, Freedland, Clouse, & Lustman, 4 
2002) and associated with increased glycosylated haemoglobin (HbA1c) (Lustman et al., 5 
2000), morbidity (de Groot, Anderson, Freedland, Clouse, & Lustman, 2001), and mortality 6 
(Park, Katon, & Wolf, 2013). Both biological (Rustad, Musselman, & Nemeroff, 2011) and 7 
behavioural (Gonzalez et al., 2008) mechanisms influence relationships between symptoms 8 
of depression and anxiety and poorer diabetes health outcomes. However, a detailed 9 
understanding of the behavioural mechanisms responsible for the relationship between 10 
depression and anxiety and poorer diabetes health outcomes is lacking.   11 
     A behavioural theory used to understand what motivates self-care behaviour in the context 12 
of illness is the Common Sense Self-Regulation Model (CS-SRM) (Leventhal, Meyer, & 13 
Nerenz, 1980). The CS-SRM argues that when presented with a health threat we initiate 14 
parallel cognitive and emotional responses. Indeed the CS-SRM hypothesises that reciprocal 15 
causal relationships exist between illness cognitions and emotional responses, which then go 16 
on to determine the types of illness self-care  and emotional coping behaviours implemented 17 
by an individual.  Thus it provides an appropriate framework to explore how depression and 18 
anxiety operates in the context of chronic illness.  19 
The cognitive response of the CS-SRM includes an appraisal of the health threat to 20 
generate an illness representation framework. This includes illness cognitions about the 21 
perceived cause of the health threat, associated symptoms, and their likely duration and 22 
predictability. It also includes cognitions about the degree of personal and treatment 23 
resources available for health threat management, its impact on functioning, and the extent to 24 
which a person has a coherent understanding of the health threat. A person’s illness 25 
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representation framework determines the types of self-care behaviours a person might 26 
implement to manage the health threat.  27 
Specifically in the context of diabetes, cross-sectional observational studies have 28 
confirmed the importance of the relationship between illness cognitions and diabetes self-29 
care. Having an optimistic diabetes appraisal including perceiving diabetes treatments to be 30 
effective and believing that one has personal resources available for managing diabetes 31 
demonstrates relatively consistent associations with improved adherence to one or more 32 
diabetes self-care behaviours: diet, exercise, and medication taking (Broadbent, Donkin, & 33 
Stroh, 2011; Hampson, Glasgow, & Foster, 1995; Hampson, Glasgow, & Toobert, 1990; 34 
Searle, Norman, Thompson, & Vedhara, 2007). Conversely, having a pessimistic appraisal of 35 
diabetes including perceiving diabetes to cause a high number of physical and social 36 
consequences (Barnes, Moss-Morris, & Kaufusi, 2004; Broadbent et al., 2011; Hampson et 37 
al., 1990) in addition to perceiving diabetes as an unpredictable condition (Barnes et al., 38 
2004) is associated with lower adherence to diabetes self-care behaviours.  39 
The CS-SRM acknowledges with equal emphasis the role of the emotional response 40 
to the health threat. This includes an emotional reaction (e.g. depression and anxiety), thus 41 
coping behaviours are simultaneously initiated to manage these emotions, for example, 42 
avoidance of medical settings.  The relationship between diabetes emotional responses and 43 
coping behaviours (e.g. avoidance, withdrawal, denial) to our knowledge has not been 44 
directly assessed, but indirectly inferred from studies demonstrating lower rates of adherence 45 
among people with higher levels of depression (Gonzalez et al., 2008).  46 
Empirical studies based on the CS-SRM have largely used cross-sectional designs and 47 
focussed on investigating direct pathways leading from illness cognitions to diabetes self-care 48 
behaviours. These studies have not taken into account the hypothesised reciprocal 49 
 6 
 
relationships that occur between illness cognitions and emotional responses and their 50 
subsequent combined effects on diabetes self-management. Thus studies have only tested 51 
partial aspects of the CS-SRM.  In the context of diabetes, cross-sectional evidence across 52 
nine studies  indicates that having a pessimistic cognitive appraisal of  diabetes heightens a 53 
person’s experience of negative emotions or vice versa (Hudson, Bundy, Coventry, & 54 
Dickens, 2014). However, we are aware of no longitudinal studies which have explored 55 
simultaneously the direct and indirect pathways through which illness cognitions and 56 
emotional responses operate to have downstream effects on diabetes self-care. 57 
      Our study thus tested the salience of the CS-SRM.  We longitudinally explored using 58 
structural equation modelling (SEM) both direct and indirect (mediated) relationships 59 
between diabetes cognitions, negative emotions, and diabetes self-care behaviours. We used 60 
SEM to explore if: i) cognitions can have a direct effect on diabetes self-care and also an 61 
indirect effect mediated through negative emotions; ii) negative emotions can have a direct 62 
effect on diabetes self-care and also an indirect effect mediated through cognitions. The 63 
hypothesised nature and direction of effects between variables is detailed below. It was not 64 
possible to define a priori the specific cognition-emotion pathways that would demonstrate a 65 
relationship with diabetes self-care because no prior studies have examined simultaneously 66 
these multiple mediator pathways over time in adults with type 2 diabetes. 67 
Study hypotheses   68 
i) Having a pessimistic cognitive appraisal of diabetes will be directly associated 69 
with lower adherence to diabetes self-care (cognitions →diabetes self-care). 70 
ii) Having a pessimistic cognitive appraisal of diabetes will be indirectly associated 71 
with lower adherence to diabetes self-care via heightened negative emotions 72 
(cognitions → emotions → diabetes self-care)  73 
 7 
 
iii) Heightened negative emotions will be directly associated with lower adherence to 74 
diabetes self-care (emotions → diabetes self-care) 75 
iv) Heightened negative emotions will be indirectly associated with lower adherence 76 
to diabetes self-care via pessimistic cognitive appraisals of diabetes (emotions → 77 
cognitions → diabetes self-care)  78 
Materials and Method 79 
 80 
Participants 81 
     At baseline people with Type 2 diabetes were recruited consecutively (face to face) from a 82 
UK diabetes outpatient clinic (central Manchester) from May 2011 to October 2011 (ethical 83 
approval reference 11/NW/0069). Participants were followed up at six months to coincide 84 
with their next bi-annual review at the outpatient clinic.  Outpatients were eligible for 85 
inclusion if they had diagnosed Type 2 diabetes and were ≥ 18 years old, but were ineligible 86 
if they had an impairment that was deemed inappropriate for participation by the person 87 
themselves, a carer or their medical team (e.g. lacked capacity, high risk of suicide). 88 
Measures 89 
 90 
     The following data were collected at baseline and six months follow-up after informed 91 
consent: 92 
Demographic and Clinical Characteristics (baseline only) 93 
 94 
Self-reported demographics: age, gender, and ethnicity. Clinical characteristics were 95 
extracted from medical records: diabetes duration, diabetes medication type, number of 96 
diabetes complications (retinopathy, neuropathy, nephropathy, cardio-vascular, 97 
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cerebrovascular, peripheral vascular, and metabolic), and number of other health co-98 
morbidities (according to International Classification of Diseases categories ICD-10) (World 99 
Health Organization, 2010). 100 
Depression and Anxiety 101 
 102 
 Depressive and anxious symptoms were measured using the Diabetes Wellbeing 103 
Questionnaire (DWBQ) (Bradley, 1994). The DWBQ has four subscales: depression (six 104 
items), anxiety (six items), energy (four items), and positive wellbeing (six items). DWBQ 105 
items are responded to on a four point Likert scale.  Only the depression and anxiety 106 
subscales were used. These subscales were adapted from Zung’s self-rating depression 107 
(Zung, Richards, & Short, 1965) and anxiety (Zung, 1974) scales specifically for use among 108 
the diabetes population. The DWBQ depression and anxiety subscales demonstrate high 109 
concurrent validity with the Hospital Anxiety and Depression scale (Pincus, Griffiths, 110 
Isenberg, & Pearce, 1997). Higher DWBQ scores indicate  higher depressive and anxious 111 
symptoms.  112 
Diabetes Illness Cognitions 113 
 114 
 Illness cognitions were measured using the revised Illness Perception Questionnaire 115 
(IPQ-R) (Moss-Morris et al., 2002) and the Beliefs about Medicines Questionnaire-specific 116 
(BMQ-specific) (Horne, Weinman, & Hankins, 1999). The IPQ-R assesses the following 117 
illness cognition domains (subjective beliefs; 70 items): identity (symptoms attributed to 118 
diabetes), timeline acute/chronic (diabetes duration), timeline cyclical (predictability of 119 
diabetes), cause (cause of diabetes), consequences (impact of diabetes), personal control 120 
(availability of individual resources for managing diabetes),  treatment control (efficacy of 121 
treatments for managing diabetes), illness coherence (degree of diabetes understanding), and 122 
emotional representations (negative emotions experienced because of diabetes). All IPQ-R 123 
 9 
 
items use a five point Likert scale excluding identity, which has a binary yes/no response 124 
based on whether symptoms are experienced and attributed to diabetes. All yes responses 125 
receive a score of one and are summed. High scores on each subscale indicate stronger 126 
endorsements of the construct measured. The BMQ-specific (Horne et al., 1999) has two 127 
subscales: medication concerns (perceived negative effects of taking medications; 5 items) 128 
and medication necessity (perceived need for taking medication to manage diabetes; 5 items). 129 
Both subscales contain five point Likert response items; higher scores indicate a stronger 130 
degree of belief in the construct.  131 
Diabetes Self-Care Behaviours 132 
 133 
The Summary of Diabetes Self-Care Activities Scale (SDSCA) (Toobert, Hampson, & 134 
Glasgow, 2000) was used to measure diabetes self-care behaviours. Participants indicated the 135 
extent to which they adhered to the following behaviours over the last seven days (eight point 136 
Likert scale ranging from zero to seven days): i) general diet (following a healthy eating 137 
plan), ii) specific diet (fruit and vegetable and fat intake), iii) exercise, iv) self-monitoring of 138 
blood glucose (SMBG), v) foot care, and vi) medication adherence. Higher scores indicate 139 
greater adherence. We combined scores across the individual SDSCA items to generate a 140 
single overall outcome measure of diabetes self-care. The diabetes self-care outcome 141 
represents the mean number of days per week a person adhered to their multi-dimensional 142 
diabetes self-care routine, an approach used by others to determine overall levels of diabetes 143 
self-care (Walker, Gebregziabher, Martin-Harris, & Egede, 2015). 144 
Statistical Analysis  145 
 146 
     Data were non-normally distributed. Descriptive statistics are reported as means and 147 
standard deviations given our relatively large sample size. Mann-Whitney U tests and 148 
Pearson chi-square tests were used to compare demographic and clinical characteristics 149 
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between completers and non-completers at follow-up. Bootstrapping (10,000 resamples) was 150 
applied to account for non-normally distributed outcomes (Mooney & Duval, 1993). 151 
Analytical model building 152 
 153 
We used a two-phase approach to building and testing our analytical models of the 154 
relationships between cognitions, emotions, and diabetes self-care. In Phase 1 we used 155 
traditional bivariate regression models to statistically test hypothesised direct and indirect 156 
pathways from cognitions and emotions to diabetes self-care; in Phase 2 we used SEM 157 
procedures, with measured variables only, to simultaneously evaluate the multiple pathways 158 
identified as statistically significant in Phase 1, to arrive at the final models. As well as 159 
testing the statistical significance of each individual pathway within the model, SEM also 160 
provides an overall assessment of how well hypothesised relationships reflect actual observed 161 
relationships in the sample dataset, providing an overall test of model validity (Kline, 2005). 162 
Goodness of fit indices are used to evaluate the overall model (See Table 1) (Kline, 2005). 163 
[INSERT TABLE 1 HERE] 164 
Phase 1 Bivariate Analyses 165 
 166 
Whilst the CS-SRM explicitly states that cognitions and emotions have the potential to 167 
directly and indirectly affect illness management behaviours, the specific pathways that apply 168 
longitudinally in the context of an outpatient Type 2 diabetes population are not known. We 169 
undertook initial (Phase 1) bivariate regression analyses in order to empirically identify 170 
potentially important direct and indirect relationships between cognitions, emotions, and 171 
diabetes self-care, for subsequent simultaneous testing using SEM. This step was necessary 172 
because simultaneous entry of all plausible directional pathways between the eight illness 173 
cognition domains, depression, anxiety, and diabetes self-care would have led to high 174 
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multicollinearity due to inter-correlated cognition domains and an unacceptably low 175 
participant to parameter ratio, affecting the reliability of the path coefficients.  The bivariate 176 
phase was therefore used to filter out non-existent or very weak paths as a first step. We 177 
therefore used a high alpha-level to avoid prematurely excluding potentially important 178 
pathways and a pathway was retained for use in SEM analyses if it was statistically 179 
significant in bivariate regression analyses at an alpha of ≤10%.  180 
Bivariate regression models were constructed to evaluate the direct effects summarised 181 
below:  182 
Baseline explanatory 
variables (Time 1) 
Directional pathway Outcome variables at 
follow-up (Time 2) 
Cognitions   → Emotions 
Emotions → Cognitions 
Cognitions → Diabetes self-care 
Emotions → Diabetes self-care 
 183 
Bivariate regression analyses also provided a test of indirect effects. Because we were limited 184 
to two time points of data collection, we applied a modified version of the Baron and Kenny 185 
(1986) approach to test for the presence of indirect effects (mediation). We used Cole and 186 
Maxwell’s (2003) two step procedure.  187 
i. Step one: Identify if the baseline explanatory variable (time 1) has a directional effect 188 
on the hypothesised mediator at follow-up (time 2) (i.e. regress the mediator at time 2 189 
on both the explanatory and mediator variable at baseline, time 1) 190 
ii. Step two: Identify if the baseline mediator variable (time 1) has a directional effect on 191 
the outcome variable at follow-up (time 2) (i.e. regress the outcome variable at time 2 192 
on both the mediator and outcome variable at baseline, time 1).   193 
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This two-step approach allowed us to use  our two waves of data collection so that: i) the 194 
effect of the explanatory variable on the mediator variable and ii) the effect of the mediator 195 
variable on the outcome variable were both tested using prospective analyses as opposed to 196 
limiting one aspect of our mediation pathway to a contemporaneous analysis only.   197 
Phase 2 SEM Model specification 198 
 199 
We produced separate SEM models for depression and anxiety because of 200 
multicollinearity between these variables (r=0.71). In each model we initially included all 201 
pathways identified as (separately) statistically significant at an alpha of ≤10% in the Phase 1 202 
bivariate regression analyses. Starting from this initial model, we sequentially trimmed 203 
pathways from the model, at each step removing the pathway with the highest p value, until 204 
all remaining pathways were significant at an alpha of ≤ 5%. This approach allows the 205 
generation of parsimonious models and promotes translation into clinical interventions 206 
(Kline, 2005).  207 
In a subsequent step we assessed the impact of potential confounders on the relationships 208 
in the final models. The impact of each potential confounder was explored separately to 209 
retain statistical power and reliability of the estimates (see phase 1 bivariate analyses for 210 
rationale). The confounders examined were: age, gender, ethnicity (white vs non-white), 211 
diabetes duration, number of diabetes complications, number of co-morbidities, and 212 
medication type (oral medication insulin/injection therapy). SEM was conducted using IBM 213 
SPSS version 19 (IBM SPSS Statistics, 2010) and Analysis of Moment Structures (AMOS) 214 
(Arbuckle, 2007) statistical software  and used complete cases analyses. 215 
Results 216 
 217 
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     Figure 1 shows the flow of participants through the study. Of the 441 participants 218 
approached at baseline, 261 completed baseline questionnaires (59% response rate). Of these, 219 
194 participants completed six month follow-up questionnaires (74% retention rate). A 220 
greater proportion of completers were of white ethnicity than non-completers (72.2% vs 221 
43.1%, p≤0.001). No other differences were found. Table 2 summarises socio-demographic 222 
and clinical characteristics of the 194 participants who returned follow-up questionnaires. 223 
Table 3 summarises mean scores on self-report measures at six months follow-up.  224 
INSERT FIG 1 AND TABLES 2 AND 3 HERE] 225 
Bivariate regression analyses 226 
Statistical appendix 1 (online supplement) presents regression coefficients and p values for all 227 
bivariate regression pathways tested. Pathways that showed a relationship with the outcome 228 
variable at alpha ≤10% are highlighted and were included for robust simultaneous testing 229 
using SEM. Figures 2 and 3 summarises the final depression and anxiety models. They 230 
include only those pathways that remained statistically significant using an alpha of 0.05 231 
when evaluated simultaneously alongside other explanatory and outcome variables using 232 
SEM.  233 
 234 
Structural Model of Relationships between Diabetes Cognitions, Negative Emotions, and 235 
Diabetes Self-Care 236 
 237 
SEM model: Diabetes Cognitions, Depression and Diabetes Self-Care 238 
 239 
The solid directional arrows in Figure 2 summarises the final SEM of the longitudinal 240 
relationships between cognitions, depression, and diabetes self-care. Only three pathways 241 
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remained statistically significant when evaluated simultaneously.  Participants who were 242 
more concerned about their diabetes at baseline were more likely to demonstrate higher 243 
depressive symptoms at six months; thus demonstrating a direct effect from cognitions 244 
(explanatory variable) to emotions (mediator). As such these findings met Cole and 245 
Maxwell’s (2003) step one criterion for the initial part of the cognition → emotion → 246 
diabetes self-care pathway. However, as indicated by an absent directional pathway from 247 
baseline depression to diabetes self-care at six months, the effect of the mediator (depression) 248 
on the outcome (diabetes self-care) was not supported. Conversely, participants with higher 249 
depression scores at baseline were more likely to believe that their diabetes was unpredictable 250 
(timeline cyclical) at six months follow-up. Thus demonstrating a direct effect from emotions 251 
(explanatory variable) to cognitions (mediator variable). This finding met Cole and 252 
Maxwell’s (2003) step one criteria for the emotion → cognition → diabetes self-care 253 
pathway. However, the pathway leading from baseline timeline cyclical (mediator variable) 254 
to diabetes self-care (outcome variable) at six months follow-up is absent from Figure 2. The 255 
effect of the mediator on the outcome was not supported according to Cole and Maxwell’s 256 
(2003) step two criteria. Baseline personal control beliefs acted autonomously from 257 
depression and had a direct effect on adherence to diabetes self-care at six months follow-up. 258 
Individuals who felt more confident in their ability to manage their diabetes at baseline 259 
showed reduced adherence to their diabetes treatment regimens over time.  260 
 We evaluated the statistical fit of the model using the goodness of fit indices and criteria 261 
summarised in Table 1. The model shown in Figure 2 had evidence of good statistical fit on 262 
all model fit indices (χ²=36.47, dfm=27, p=0.11; RMSEA=.05, CFI=.98, SRMR=.05, N=154).  263 
[INSERT FIGURE 2 HERE] 264 
SEM model: Diabetes cognitions, Anxiety, and Diabetes Self-Care 265 
 266 
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  The solid arrows in Figure 3 depicts the final SEM for the directional relationships between 267 
cognitions, anxiety, and diabetes self-care. Five pathways were statistically significant using 268 
an alpha of 0.05. Figure 3 shows that individuals who were more concerned about their 269 
diabetes at baseline had greater symptoms of anxiety at six months. Thus indicating a direct 270 
effect of cognitions (explanatory variable) on anxiety (mediator variable). However because a 271 
pathway leading from baseline anxiety (mediator variable) to diabetes self-care (outcome 272 
variable) at six months follow-up is absent, Cole and Maxwell’s (2003) step two criteria for 273 
establishing longitudinal mediation for the cognition → emotion → diabetes self-care 274 
pathway was not supported.  Conversely, individuals who were more anxious at baseline had 275 
higher beliefs in the unpredictable nature of diabetes (timeline cyclical), attributed greater 276 
importance to their diabetes medications for managing their condition (medication necessity), 277 
and had greater concerns about the potential consequences of their diabetes medications 278 
(medication concerns). Thus demonstrating the direct effect of anxiety (explanatory variable) 279 
on cognitions (mediator variables) and met Cole and Maxwell’s (2003) step one criteria for 280 
the initial part of the emotion → cognition → diabetes self-care pathway. However because 281 
Figure 3 does not include any directional pathways leading from baseline timeline cyclical, 282 
medication necessity, and medication concerns to diabetes self-care the effect of the mediator 283 
(cognitions) on the outcome (diabetes self-care) was not supported.  Consistent with the 284 
depression model, baseline personal control beliefs acted independently of emotions to 285 
influence the degree of adherence to diabetes self-care at six months follow-up.  286 
We evaluated the overall model fit of all of the directional pathways included in our 287 
anxiety model, using model fit indices and criteria described in Table 1. The model shown in 288 
Figure 3, had evidence of good statistical fit on all fit indices, excluding the model chi-square 289 
statistic (χ²=57.45, dfm=40, p=.04; RMSEA=.04, CFI=.97, SRMR=.05, N=153).  290 
[INSERT FIGURE 3 HERE] 291 
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Potential confounders 292 
 293 
In both models the statistical significance of directional pathways remained 294 
unchanged after controlling for potential confounders, with three exceptions. In both models 295 
the directional pathway leading from baseline personal control to diabetes self-care became 296 
statistically non-significant when number of diabetes complications was added as a covariate. 297 
Specifically for the depression model, baseline depression scores did not explain variance in 298 
the timeline cyclical cognition at six months, after controlling for diabetes treatment regimen. 299 
Similarly, for anxiety, the directional pathway from baseline medication concerns to anxiety 300 
at six months follow-up was not significant when diabetes duration was controlled for.   301 
Discussion 302 
 303 
 This is the first study to simultaneously examine directional relationships between 304 
cognitions, emotions, and diabetes self-care in an outpatient type 2 diabetes population. Our 305 
findings support our theoretically driven hypothesis that cognitions have direct effects on 306 
diabetes self-care. Indeed, we found that personal control beliefs operated independently of 307 
emotions to influence adherence to diabetes self-care over time. However contrary to our 308 
hypothesis about the nature of this relationship, we found that individuals who felt more 309 
confident in their ability to self-manage their diabetes actually adhered less to their diabetes 310 
self-care treatments over time. Furthermore, this effect was not sustained once number of 311 
diabetes complications was added as a covariate to both the depression and anxiety models.  312 
 Consistent with the CS-SRM (Leventhal et al., 1980) and CBT treatment models 313 
(Beck et al., 1979), we identified a reciprocal relationship between cognitions and emotions.  314 
Diabetes medication concerns had a longitudinal effect on depressive and anxious symptoms.  315 
Equally higher levels of depression and anxiety influenced diabetes cognition domains over 316 
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time, specifically: timeline cyclical, medication necessity (anxiety only), and medication 317 
concerns (anxiety only). These relationships identify potentially salient mechanisms to target 318 
when managing negative emotions in the context of Type 2 diabetes.   However, contrary to 319 
our hypotheses, our findings did not support the combined effects of these cognition-emotion 320 
pathways on diabetes self-care.  More specifically negative emotions had no direct effect on 321 
diabetes self-care. Despite finding that medication concerns increased both depressive and 322 
anxious symptoms over time, neither depression nor anxiety mediated the effect of 323 
medication concerns on diabetes self-care, as indicated by these pathways being absent from 324 
the models. Conversely, we found no evidence to support the hypothesis that diabetes 325 
cognitions mediate the effect of depression and anxiety on diabetes self-care. Although we 326 
identified an explanatory effect of depression and/or anxiety on three illness cognition 327 
domains over time, none of these domains demonstrated associations with diabetes self-care. 328 
Strengths and limitations 329 
 330 
Our study used a longitudinal design, thus our findings about the directional relationships 331 
in the models are robust (Kenny, 1979). A relatively large sample was recruited (n=261) of 332 
which 73.3% (n=194) were retained at six months follow-up. A quarter of our sample were 333 
individuals from black and minority ethnic groups, making it representative of the wider UK 334 
diabetes outpatient population. The use of SEM enabled multiple pathways to be modelled 335 
simultaneously, yielding a more valid representation of the competing relationships between 336 
cognitions, emotions, and diabetes self-care (Kline, 2005) and allowed a theoretically driven 337 
approach to our analyses. The validity of our findings is bolstered further due to confirmation 338 
that observed directional pathways between variables remained unchanged when potential 339 
demographic and clinical confounders were accounted for, excluding the confounding roles 340 
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of diabetes complications, diabetes duration, and medication type - the implications of which 341 
are discussed below.  342 
     Limitations of our study include a relatively short follow up period, which may have 343 
prevented the detection of important associations. Participants’ health in this study was likely 344 
stable given their mean diabetes duration of 14 years and because they were recruited from 345 
ambulatory outpatient clinics as opposed to settings that care for more severely ill patients. 346 
The temporal relationships that exist between illness cognitions, emotions, and diabetes self-347 
care are largely unknown. There may be critical incidents in a person’s diabetes illness 348 
trajectory that trigger change (e.g. complication onset), but to measure this would require 349 
approaches with much longer follow-up intervals. Relatedly, this study was limited to two 350 
data collection time points, which prevented the full testing of theoretically driven indirect 351 
pathways across three time points. We attempted to overcome this issue by implementing the 352 
Cole and Maxwell (2003) two-step procedure, which allowed us to test each hypothesised 353 
directional pathway longitudinally. However, we need to be mindful that our findings from 354 
our hypothesised mediators to diabetes self-care may not accurately reflect relationships that 355 
could have occurred had we been able to obtain data from a third follow-up time point. 356 
Second, because this study was exploratory, specifically in relation to identifying the 357 
longitudinal cognition-emotion profiles  relevant to a Type 2 diabetes outpatient population, 358 
we did not want to discount potentially important relationships (Rothman, 1990), so no 359 
adjustments for multiple testing (bonferroni corrections) were made.  360 
What are the combined effects of negative emotions and illness cognitions on self-care in 361 
adults with type 2 diabetes?  362 
 363 
Our findings have identified that illness cognitions can remain independent of emotions 364 
and have directional effects on diabetes self-care. Contrary to previous cross-sectional 365 
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findings showing an association between high levels of confidence in personal capabilities for 366 
managing diabetes (personal control) and improved adherence (Broadbent et al., 2011; 367 
Watkins et al., 2000); our findings showed that patients who felt more confident in their 368 
ability to manage diabetes demonstrated reduced adherence to their diabetes self-care 369 
behaviours over time. The mean diabetes duration of our sample was 14 years, therefore 370 
participants may have developed automatic habitual coping behaviours for managing 371 
diabetes, consistent with findings in hypertension, where habit strength was the strongest 372 
predictor of adherence (Phillips, Leventhal, & Leventhal, 2013). Participants in our sample 373 
possibly felt confident in undertaking their day-to-day diabetes management routines, but 374 
these routines likely deviated from the recommendations of health care professionals, 375 
identifying the need for regular reviews of diabetes self-care behaviours during clinical 376 
consultations. The role of clinical confounders warrants attention. The directional effect of 377 
personal control on diabetes self-care was no longer statistically significant when number of 378 
diabetes complications was included as a covariate in both the depression and anxiety 379 
models. This finding may not be surprising given that the presence of diabetes related 380 
complications has been identified as a key motivator for change in diabetes self-care 381 
behaviours (van Puffelen et al., 2015). This has important clinical implications about how we 382 
can support the prevention of future diabetes complications and identified the need to harness 383 
patients personal control beliefs effectively using intervention techniques such as 384 
motivational interviewing (Miller & Rollnick, 2012). 385 
Our study reinforces the claims of the CS-SRM (Leventhal et al., 1980) and highlights the 386 
salience of reciprocal relationships between cognitions and emotions, which can contribute to 387 
the maintenance and exacerbation of depression and anxiety in diabetes. Consistent with 388 
cognitive-behavioural therapy (Beck, 1964) and our hypotheses, having a pessimistic 389 
appraisal of diabetes treatments heightened participant’s experience of depression and anxiety 390 
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over time. But equally depression and anxiety influenced participants beliefs about diabetes 391 
in a pessimistic manner, likely occurring because of altered attentional control processes in 392 
response to arousal (Cameron, 2003).  In heightened states of arousal attention can become 393 
focussed on somatic symptom detection, thus a person’s diabetes cognitive illness 394 
representation is updated in response to identified somatic changes. But equally mood may be 395 
unhelpfully used as a heuristic for physical heath (Leventhal et al., 1980). Somatic symptoms 396 
of depression and anxiety (including shaking, sweating, low energy) overlap with symptoms 397 
of hypoglycaemia, thus leading to the misattribution of physical symptoms provoked by 398 
emotions, to diabetes.  The longitudinal relationships observed in our study between 399 
cognitions and emotions are largely consistent with cross-sectional findings (Hudson et al., 400 
2014). However we did not identify longitudinal associations between increased perceived 401 
consequences and poorer emotional health and likewise lower perceptions of personal control 402 
and poorer emotional health, despite cross-sectional studies consistently reporting these 403 
effects  (Hudson et al., 2014). 404 
It is important to acknowledge that depression made no statistically significant 405 
contribution to the timeline cyclical cognition domain when modelled alongside a person’s 406 
diabetes medication treatment regimen. The intensity of a person’s medication regimen varies 407 
as a function of their degree of blood glucose dysregulation. Thus it is plausible that 408 
individuals with poorer blood glucose control who as a result are prescribed more intensive 409 
diabetes medication regimens experience greater levels of depression. As such diabetes 410 
treatment regimens have the potential to moderate the degree of depression experienced and 411 
ultimately the extent to which this goes on to influence a person’s appraisal of their diabetes 412 
in a moderated-mediation pathway.  In addition, the explanatory effect of medication 413 
concerns on anxiety became statistically non-significant when diabetes duration was included 414 
as a model covariate. Consistent with the CS-SRM, it is likely that individuals with a longer 415 
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diabetes duration have developed effective coping strategies for managing their threatening 416 
diabetes medication perceptions and thus have emotionally adjusted to these concerns. As 417 
such it is important to consider how salient mechanisms of action within CS-SRM differ 418 
depending on the context of a person’s illness trajectory (e.g. newly diagnosed vs stable 419 
condition).   420 
Whilst our findings identified the importance of reciprocal relationships between 421 
cognitions and emotions, the absence of their combined effects on diabetes self-care is 422 
surprising and contrary to our research hypotheses. Among individuals who are experiencing 423 
more severe symptoms of depression and anxiety, these cognition-emotion pathways and vice 424 
versa, may well go on to influence diabetes self-care behaviour. Indeed, it is worthy to note, 425 
that these relationships were identified in our study, when neither emotions nor cognitions 426 
were explicitly manipulated. Thus the degree of explanatory effects is attenuated. In addition 427 
participants in our sample showed relatively low levels of depression and anxiety symptoms, 428 
which may at least partly account for our null findings. Previous studies that have shown a 429 
relationship between depression and diabetes outcomes over time have included clinically 430 
depressed populations (Dirmaier et al., 2010; Katon et al., 2010; Lin et al., 2004). 431 
Nonetheless, our sample’s mean levels of depression and anxiety are consistent with others 432 
who have used the DWBQ in people with Type 2 diabetes (French et al., 2008; Paschalides et 433 
al., 2004), and thus can be considered representative of a general diabetes outpatient 434 
population. 435 
Clinical implications 436 
Psychological interventions to date that have addressed depression and anxiety in the 437 
context of diabetes have improved mental health outcomes but corresponding achievements 438 
in diabetes health outcomes (HbA1c) are lacking (Harkness et al., 2010).  By testing the CS-439 
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SRM longitudinally a comprehensive model the illness specific cognitive-behavioural 440 
pathways through which depression and anxiety operate in the context of diabetes can be 441 
developed. This will allow the development of modified interventions that better integrate the 442 
management of physical and mental health, a priority identified for health care 443 
commissioners (Imison et al., 2011), whilst  also decreasing the burden of care for patients 444 
with multimorbidity (Mercer et al., 2012). Cognitive-behavioural therapy (Beck, 1976) is a 445 
treatment that can target the causal mechanisms outlined in the CS-SRM. Our study should 446 
be replicated in a larger sample with moderation analyses to compare cognition, emotion, and 447 
behavioural outcome profiles among people who meet diagnostic thresholds for depression 448 
and/or anxiety with those who do not. This will help to isolate pathways that need to be 449 
addressed in self-management interventions based on patient clinical presentations and will 450 
lead to the development of more personalised and efficient psychological medicine. 451 
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Table 1: Goodness of Fit Indices used to evaluate models 
Goodness of fit index Statistical interpretation 
Model chi-square χ² Smaller χ² = better model fit. Requires a true null hypothesis.  
Comparative Fit Index (CFI) Values close to 0.95 indicate a good fit.  
Root Mean Square Error of 
Approximation (RMSEA) 
Values ≤ 0.06 indicate good fit.  
 
Standardised Root Mean Square 
Residual (SRMR) 
Values ≤0.10 indicate good fit. 
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Table 2: Demographic and clinical characteristics of participants at 6 months follow-up  
Variable Mean/ 
Frequency 
Standard Deviation/ 
Percentage  
Gender Male 120 61.9 
 Female 74 38.1 
    
Age/years mean 62.8 11.9 
 median 63.0 55.0-72.0 
Ethnicity White 140 72.2 
 Black 25 12.9 
 Asian 24 12.4 
 Mixed race 4 2.1 
 Other/prefer not to say 1 0.52 
Diabetes duration/years mean 14.3 8.8 
 median 13.0 8.3-19.0 
Diabetes treatment regimen Diet/oral hypoglycaemics 53 27.3 
 Injections/Combination  128 66.0 
 No access to medical records/missing 
data  
13 6.7 
    
Clinical outcomes    
HbA1c mmol/mol  65.6 16.7 
Number of complications  2.0 1.2 
Number of other co-morbidities  1.5 1.2 
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Table 3: Follow-up scores on self-report measures of depression, anxiety, diabetes 
cognitions, and diabetes self-care  
Variables   Mean Standard Deviation Cronbach’s alpha 
Well-being questionnaire   
Depression  4.7 3.6 0.84 
Anxiety  5.4 4.2 0.83 
Illness Perception Questionnaire-Revised   
Identity  3.8 3.2 0.77 
Timeline acute/chronic  4.2 0.7 0.73 
Timeline cyclical  2.9 1.0 0.82 
Consequences  3.3 0.8 0.80 
Personal control  4.0 0.7 0.77 
Treatment control  3.6 0.6 0.53 
Illness coherence  3.6 0.9 0.90 
Emotional representations  2.7 1.0 0.88 
Beliefs about Medicines Questionnaire  
 
 
Medication necessity  4.1 0.8 0.89 
Medication concerns  2.8 1.0 0.80 
Summary of diabetes self-care activity scale   
General diet  5.0 2.1 0.92 
Specific diet (fruit & veg)  4.7 2.3 Single item NA 
Specific diet (saturated fat)  4.5 2.0 Single item NA 
Exercise  2.3 2.3 0.79 
Self-monitoring of blood glucose  4.6 2.7 0.90 
Foot care  3.7 2.6 0.65 
Medication adherence  6.8 0.9 Single item NA 
Global diabetes self-care  3.9 1.3 0.62 
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Figure headings and captions 
Figure 1: Flow chart of participants recruited and retained at each stage of the study  
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Figure 2: Final model of the simultaneous effect of cognitions and depression on diabetes self-care 
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Figure 3: Final model of the simultaneous effect of cognitions and anxiety on diabetes self-care 
 
 
Figure captions:  
Figure 1: Recruitment and retention flow diagram 
Figure 2 & 3: Statistics reported next to directional arrows are standardised regression coefficients. Those 
aligned left refer to auto-regressive pathways. Those aligned right refer to directional pathways.  Statistics 
adjacent to outcome variable detail the percentage variance explained. All baseline variables were specified 
to correlate with each other.  
Key:  *p≤0.05, **p≤0.01, ***, p≤0.001 
 
 
